DOI:
https://doi.org/10.71337/inlibrary.uz.universaljurnal.111318Kalit so‘zlar:
Precision medicine CRISPR immunotherapy regenerative medicine artificial intelligence mRNA technology microbiome therapy.Annotasiya
Biotibbiyotning tez rivojlanishi tufayli paradigma o'zgarishi kuzatilmoqda
texnologiya va molekulyar biologiya. Rivojlanayotgan yondashuvlar, masalan, aniq tibbiyot, genlarni tahrirlash,
immunoterapiya va sun'iy intellekt kasalliklarni aniqlash, davolash usullarini o'zgartiradi.
va oldini oldi. CRISPR, mRNK platformalari va kabi yangi texnologiyalarning integratsiyasi
mikrobiomaga asoslangan davolash usullari yanada moslashtirilgan, samarali va samarali davolash usullarini yaratmoqda. Bu
Maqolada biotibbiyot sohasidagi so'nggi tendentsiyalar va terapevtik strategiyalar o'rganilib, ularning klinik ko'rinishi tahlil qilinadi.
ta'siri, hozirgi cheklovlar va kelajakdagi rivojlanish imkoniyatlari.
Bibliografik manbalar
Collins, F. S., & Varmus, H. (2015). A new initiative on precision medicine. New England Journal of Medicine, 372(9), 793-795.
Frangoul, H., et al. (2021). CRISPR-Cas9 gene editing for sickle cell disease and betathalassemia. New England Journal of Medicine, 384(3), 252-260.
June, C. H., et al. (2018). CAR T cell immunotherapy for human cancer. Science, 359(6382), 1361-1365.
Lloyd-Price, J., et al. (2016). The healthy human microbiome. Genome Medicine, 8(1),
Murphy, S. V., & Atala, A. (2014). 3D bioprinting of tissues and organs. Nature Biotechnology, 32(8), 773-785.
Sahin, U., et al. (2014). mRNA-based therapeutics-developing a new class of drugs. Nature Reviews Drug Discovery, 13(10), 759-780.
Topol, E. (2019). High-performance medicine: the convergence of human and artificial intelligence. Nature Medicine, 25(1), 44-56.
